A detailed history of Black Rock Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,249,368 shares of AXGN stock, worth $50.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,249,368
Previous 3,232,207 0.53%
Holding current value
$50.8 Million
Previous $26.1 Million 9.81%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.67 - $8.06 $97,302 - $138,317
17,161 Added 0.53%
3,249,368 $23.5 Million
Q1 2024

May 10, 2024

SELL
$6.63 - $10.69 $733,052 - $1.18 Million
-110,566 Reduced 3.31%
3,232,207 $26.1 Million
Q4 2023

Feb 13, 2024

BUY
$3.61 - $7.76 $354,967 - $763,033
98,329 Added 3.03%
3,342,773 $22.8 Million
Q3 2023

Nov 13, 2023

SELL
$4.68 - $9.26 $219,024 - $433,368
-46,800 Reduced 1.42%
3,244,444 $16.2 Million
Q2 2023

Aug 11, 2023

BUY
$8.5 - $10.38 $1.01 Million - $1.23 Million
118,764 Added 3.74%
3,291,244 $30 Million
Q1 2023

May 12, 2023

BUY
$7.53 - $10.95 $98,417 - $143,116
13,070 Added 0.41%
3,172,480 $30 Million
Q4 2022

Feb 13, 2023

BUY
$9.44 - $13.09 $2.4 Million - $3.33 Million
254,159 Added 8.75%
3,159,410 $31.5 Million
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $62,336 - $93,810
7,658 Added 0.26%
2,905,251 $34.6 Million
Q2 2022

Aug 12, 2022

SELL
$6.99 - $10.0 $829,027 - $1.19 Million
-118,602 Reduced 3.93%
2,897,593 $23.7 Million
Q1 2022

May 12, 2022

BUY
$7.26 - $10.7 $51,161 - $75,402
7,047 Added 0.23%
3,016,195 $24 Million
Q4 2021

Feb 10, 2022

BUY
$8.8 - $16.0 $633,160 - $1.15 Million
71,950 Added 2.45%
3,009,148 $28.2 Million
Q3 2021

Nov 09, 2021

BUY
$15.23 - $21.72 $804,737 - $1.15 Million
52,839 Added 1.83%
2,937,198 $46.4 Million
Q2 2021

Aug 11, 2021

BUY
$17.8 - $23.5 $51.3 Million - $67.8 Million
2,884,359 New
2,884,359 $62.3 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.